
CapMan
CapMan has appointed Yrjö Wichmann as investment director in its Nordic life science business unit. Wichmann has over ten years' experience in the Finnish life science market, his most recent appointment being with FibroGen Europe Corp, where he acted as CFO. Previously, he worked at D Carnegie AB's Finland branch as a director in corporate finance, responsible for the life science and healthcare sectors.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater
Back to Top